Merit Medical Systems (MM3) Stock Forecast & Price Target

1 Followers

See the Price Targets and Ratings of:

All Analysts

Top Analysts

Premium

MM3 Analyst Ratings

Strong Buy

8 Buy

2 Hold

0 Sell

Based on 10 analysts giving stock ratings to

Merit

Medical Systems

in the past 3 months

TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers in the past 3 months

MM3 Stock 12 Month Forecast

Average Price Target

€85.45

▲(10.26% Upside)

Based on 10 Wall Street analysts offering 12 month price targets for Merit Medical Systems in the last 3 months. The average price target is €85.45 with a high forecast of €97.85 and a low forecast of €71.24. The average price target represents a 10.26% change from the last price of €77.50.

{"navigator":{"disabled":true},"exporting":{"enabled":false},"title":{"text":null},"chart":{"height":200,"style":{"fontFamily":"Roboto Flex, -apple-system, BlinkMacSystemFont, Segoe UI, Roboto, Helvetica, Arial, sans-serif, Apple Color Emoji, Segoe UI Emoji, Segoe UI Symbol","fontWeight":"400","color":"#5d5d5e"},"spacingTop":30,"spacingRight":60,"events":null},"yAxis":{"labels":{"style":{"color":"inherit"},"distance":6,"x":-6,"y":-6,"zIndex":1,"map_label_formatter":{"52":"€52","75":"€75","98":"€98","63.5":"€63.5","86.5":"€86.5"}},"plotLines":[{"color":"rgba(0,0,0,0)","value":97.85306964,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":-10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-bottom flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#199ca5\">High </span>\n\n  <span style=\"color:#199ca5\">€97.85</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":85.45453255111111,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":0,"text":"<div  class=\"positionrelative hoverZ3 triangleleft flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#828080\">Average </span>\n\n  <span style=\"color:#828080\">€85.45</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":71.24390158,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-top flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#912767\">Low </span>\n\n  <span style=\"color:#912767\">€71.24</span>\n  </div></div>","useHTML":true}}],"tickPositions":[52,63.5,75,86.5,98],"lineColor":"#dddddd","gridLineWidth":1,"gridLineColor":"#dddddd","lineWidth":1,"title":{"text":""}},"plotOptions":{"series":{"states":{"inactive":{"opacity":1}}},"line":{"animation":{"duration":0},"dataLabels":{"allowOverlap":true},"borderWidth":1,"marker":{"enabled":true,"fillColor":"#FFFFFF","radius":3,"lineWidth":2,"symbol":"circle","lineColor":"#828080"}}},"xAxis":{"labels":{"style":{"color":"inherit"},"rotation":0,"map_label_formatter":{"3":"Nov<br/>2025","6":"Feb<br/>2026","9":"May<br/>2026","12":"Aug<br/>2026","25":"Aug<br/>2027"}},"tickPositions":[3,6,9,12,25],"plotLines":[{"color":"#dddddd","width":1,"value":12},{"color":"#dddddd","width":1,"value":12}],"lineWidth":0,"gridLineWidth":1,"gridLineColor":"#dddddd","tickLength":0},"legend":{"symbolRadius":0,"symbolPadding":4,"symbolHeight":14,"borderWidth":0,"symbolWidth":14,"align":"left","verticalAlign":"bottom","enabled":false},"tooltip":{"backgroundColor":"rgba(0,0,0,0)","useHTML":true,"borderWidth":0,"borderColor":"rgba(0,0,0,0)","padding":0,"shadow":null,"headerFormat":"","footerFormat":"","pointFormat":"<div class=\"flexccc lineHeight2 bgwhite shadow2 px3 py3 radiismall fonth10_semibold\">\n                <span class=\"colorgray-3 mb4\">{point.date:%b %d ,%Y}</span>\n                <span>Analyst Consensus</span>\n                {point.info}\n          </div>\n           </div>"},"credits":{"enabled":false},"accessibility":{"description":""},"responsive":{"rules":[{"chartOptions":{"chart":{"spacing":[0,0,0,0],"margin":[30,60,40,5]},"xAxis":{"tickPositions":[3,12,25.25]},"yAxis":{"labels":{"enabled":false}},"title":{"text":null},"subtitle":{"text":null}},"condition":{"maxWidth":500}}]},"series":[{"lineWidth":2,"dashStyle":"ShortDash","name":"High","type":"line","color":"#199ca5","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,73.5,75.37331304923077,77.24662609846153,79.1199391476923,80.99325219692308,82.86656524615384,84.73987829538461,86.61319134461539,88.48650439384616,90.35981744307692,92.2331304923077,94.10644354153845,95.97975659076923,{"y":97.85306964,"marker":{"fillColor":"#199ca5","lineColor":"#199ca5","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Average","type":"line","color":"#828080","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,73.5,74.41957942700854,75.3391588540171,76.25873828102564,77.17831770803419,78.09789713504273,79.01747656205129,79.93705598905983,80.85663541606837,81.77621484307693,82.69579427008547,83.61537369709401,84.53495312410257,{"y":85.45453255111111,"marker":{"fillColor":"#828080","lineColor":"#828080","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Low","type":"line","color":"#912767","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,73.5,73.3264539676923,73.15290793538462,72.97936190307692,72.80581587076924,72.63226983846154,72.45872380615384,72.28517777384616,72.11163174153846,71.93808570923076,71.76453967692308,71.59099364461538,71.4174476123077,{"y":71.24390158,"marker":{"fillColor":"#912767","lineColor":"#912767","enabled":true,"symbol":"circle"}}]},{"type":"line","data":[{"y":73,"date":1754006400000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 21,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":76,"date":1756684800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 21,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":70,"date":1759276800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 12,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":75.5,"date":1761955200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 14,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":74.5,"date":1764547200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 15,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 2, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":74,"date":1767225600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 12,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":69,"date":1769904000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 15,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 3, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":65.5,"date":1772323200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 15,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 2, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":58.5,"date":1775001600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 16,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 2, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":57,"date":1777593600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 17,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 2, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":53.5,"date":1780272000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 16,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 2, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":60,"date":1782864000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 19,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 4, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":73.5,"date":1785542400000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 14,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 2, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"fillColor":"black","lineColor":"black","enabled":true,"symbol":"circle"}},null,null,null,null,null,null,null,null,null,null,null,null],"color":"#0666a7"}]}

Highest Price Target€97.85

Average Price Target€85.45

Lowest Price Target€71.24

The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.

Detailed List of Analyst Forecasts

Sam Eiber

BTIG

€90.13

Buy

16.29%

Upside

Reiterated

08/11/26

Analysts Have Conflicting Sentiments on These Healthcare Companies: Hims & Hers Health (NYSE: HIMS), Merit Medical Systems (NASDAQ: MMSI) and Intuitive Surgical (NASDAQ: ISRG)

John Young CFA

Canaccord Genuity

€80.69

Buy

4.11%

Upside

Reiterated

08/11/26

Canaccord Genuity Sticks to Its Buy Rating for Merit Medical Systems (MMSI)

Robbie Marcus

J.P. Morgan

€81.54

Buy

5.22%

Upside

Reiterated

08/04/26

J.P. Morgan Remains a Buy on Merit Medical Systems (MMSI)

Jayson Bedford

Raymond James

€71.24→€85.84

Buy

10.76%

Upside

Reiterated

07/31/26

Merit Medical price target raised to $100 from $83 at Raymond JamesMerit Medical price target raised to $100 from $83 at Raymond James

Michael Matson

Needham

€77.25→€86.69

Buy

11.86%

Upside

Reiterated

07/31/26

Analysts Are Bullish on Top Healthcare Stocks: Merit Medical Systems (MMSI), Siemens Healthineers AG (SEMHF)

Larry Biegelsen

Wells Fargo

€63.52→€71.24

Hold

-8.07%

Downside

Assigned

07/31/26

Wells Fargo Issues a Hold Rating on Merit Medical Systems (MMSI)

David Rescott

Robert W. Baird

€76.39→€84.12

Buy

8.54%

Upside

Reiterated

07/31/26

Merit Medical price target raised to $98 from $89 at BairdMerit Medical price target raised to $98 from $89 at Baird

Michael Petusky

Barrington

€91.84→€97.85

Buy

26.26%

Upside

Reiterated

07/31/26

Merit Medical price target raised to $114 from $107 at BarringtonMerit Medical price target raised to $114 from $107 at Barrington

Travis Steed

Bank of America Securities

―

Hold

―

Reiterated

07/31/26

Analysts Offer Insights on Healthcare Companies: Moleculin Biotech (NASDAQ: MBRX), Merit Medical Systems (NASDAQ: MMSI) and Moderna (NASDAQ: MRNA)

Jason Bednar

Piper Sandler

€82.4→€90.99

Buy

17.40%

Upside

Reiterated

07/31/26

Merit Medical Systems (MMSI) Gets a Buy from Piper Sandler

James Sidoti

Sidoti

€104.72

Buy

35.12%

Upside

Reiterated

01/09/26

Wall Street Analysts Are Bullish on Top Healthcare Picks

Analyst Type

Any

Human Analysts

Ranks

Any

Analyst Rating

Any

Upside/ Downside

Any

Action

Any

Sam Eiber

BTIG

€90.13

Buy

16.29%

Upside

Reiterated

08/11/26

Analysts Have Conflicting Sentiments on These Healthcare Companies: Hims & Hers Health (NYSE: HIMS), Merit Medical Systems (NASDAQ: MMSI) and Intuitive Surgical (NASDAQ: ISRG)

John Young CFA

Canaccord Genuity

€80.69

Buy

4.11%

Upside

Reiterated

08/11/26

Canaccord Genuity Sticks to Its Buy Rating for Merit Medical Systems (MMSI)

Robbie Marcus

J.P. Morgan

€81.54

Buy

5.22%

Upside

Reiterated

08/04/26

J.P. Morgan Remains a Buy on Merit Medical Systems (MMSI)

Jayson Bedford

Raymond James

€71.24→€85.84

Buy

10.76%

Upside

Reiterated

07/31/26

Merit Medical price target raised to $100 from $83 at Raymond JamesMerit Medical price target raised to $100 from $83 at Raymond James

Michael Matson

Needham

€77.25→€86.69

Buy

11.86%

Upside

Reiterated

07/31/26

Analysts Are Bullish on Top Healthcare Stocks: Merit Medical Systems (MMSI), Siemens Healthineers AG (SEMHF)

Larry Biegelsen

Wells Fargo

€63.52→€71.24

Hold

-8.07%

Downside

Assigned

07/31/26

Wells Fargo Issues a Hold Rating on Merit Medical Systems (MMSI)

David Rescott

Robert W. Baird

€76.39→€84.12

Buy

8.54%

Upside

Reiterated

07/31/26

Merit Medical price target raised to $98 from $89 at BairdMerit Medical price target raised to $98 from $89 at Baird

Michael Petusky

Barrington

€91.84→€97.85

Buy

26.26%

Upside

Reiterated

07/31/26

Merit Medical price target raised to $114 from $107 at BarringtonMerit Medical price target raised to $114 from $107 at Barrington

Travis Steed

Bank of America Securities

―

Hold

―

Reiterated

07/31/26

Analysts Offer Insights on Healthcare Companies: Moleculin Biotech (NASDAQ: MBRX), Merit Medical Systems (NASDAQ: MMSI) and Moderna (NASDAQ: MRNA)

Jason Bednar

Piper Sandler

€82.4→€90.99

Buy

17.40%

Upside

Reiterated

07/31/26

Merit Medical Systems (MMSI) Gets a Buy from Piper Sandler

James Sidoti

Sidoti

€104.72

Buy

35.12%

Upside

Reiterated

01/09/26

Wall Street Analysts Are Bullish on Top Healthcare Picks

Stocks with the Highest Top Analyst Consensus in the Healthcare Sector

ODTXOdyssey Therapeutics, Inc.

BTSGBrightSpring Health Services, Inc.

GPCRStructure Therapeutics, Inc. Sponsored ADR

AMLXAmylyx Pharmaceuticals Inc

IMMXImmix Biopharma

Find stocks in the Healthcare sector that are highly recommended by Top Performing Analysts.

Best Analysts Covering Merit Medical Systems

3 Months

Jayson BedfordRaymond James

Success Rate

27/33 ratings generated profit

Average Return

+10.80%

Copying Jayson Bedford's trades and holding each position for 3 Months would result in 81.82% of your transactions generating a profit, with an average return of +10.80% per trade.

1 Year

Michael PetuskyBarrington

Success Rate

35/51 ratings generated profit

Average Return

+12.87%

Copying Michael Petusky's trades and holding each position for 1 Year would result in 68.63% of your transactions generating a profit, with an average return of +12.87% per trade.

2 Years

Michael PetuskyBarrington

Success Rate

36/51 ratings generated profit

Average Return

+15.89%

Copying Michael Petusky's trades and holding each position for 2 Years would result in 70.59% of your transactions generating a profit, with an average return of +15.89% per trade.

The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.

MM3 Analyst Recommendation Trends

Rating

Apr 26

May 26

Jun 26

Jul 26

Aug 26

Strong Buy

Buy

Hold

Sell

Strong Sell

total

In the current month, MM3 has received 14 Buy Ratings, 2 Hold Ratings, and 0 Sell Ratings. MM3 average Analyst price target in the past 3 months is 85.45.

Each month's total comprises the sum of three months' worth of ratings.

MM3 Financial Forecast

MM3 Earnings Forecast

Next quarter’s earnings estimate for MM3 is €0.89 with a range of €0.87 to €0.91. The previous quarter’s EPS was €1.03. MM3 beat its EPS estimate ― of the time in the past 12 months, while its overall industry beat the EPS estimate 57.80% of the time in the same period. In the last calendar year MM3 has Performed in-line its overall industry.

MM3 Sales Forecast

Next quarter’s sales forecast for MM3 is €354.43M with a range of €353.24M to €356.00M. The previous quarter’s sales results were €362.30M. MM3 beat its sales estimates ― of the time in past 12 months, while its overall industry beat sales estimates 50.04% of the time in the same period. In the last calendar year MM3 has Performed in-line its overall industry.

MM3 Stock Forecast FAQ

What is DE:MM3’s average 12-month price target, according to analysts?

Based on analyst ratings, Merit Medical Systems’s 12-month average price target is 85.45.

What is DE:MM3’s upside potential, based on the analysts’ average price target?

Merit Medical Systems has 10.26% upside potential, based on the analysts’ average price target.

Can I see which stocks the top-ranking analysts are rating?

Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.

How can I follow the stock ratings of top Wall Street analysts?

Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.

Is Merit Medical Systems a Buy, Sell or Hold?

Merit Medical Systems has a consensus rating of Strong Buy, which is based on 8 buy ratings, 2 hold ratings and 0 sell ratings.

What is Merit Medical Systems’s share price target?

The average share price target for Merit Medical Systems is 85.45. This is based on 10 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
The highest analyst share price target is €97.85 ,and the lowest forecast is €71.24. The average share price target represents 10.26% Increase from the current price of €77.5.

What do analysts say about Merit Medical Systems?

Merit Medical Systems’s analyst rating consensus is a Strong Buy. This is based on the ratings of 10 Wall Streets Analysts.

How can I buy shares of Merit Medical Systems?

To buy shares of DE:MM3, you can open a brokerage account. See exclusive account opening deals on our Best Online Brokers page.

Merit Medical Systems (MM3) Stock Forecast & Price Target

MM3 Analyst Ratings

MM3 Stock 12 Month Forecast

Average Price Target

Detailed List of Analyst Forecasts​

Best Analysts Covering Merit Medical Systems

MM3 Analyst Recommendation Trends

MM3 Financial Forecast

MM3 Earnings Forecast

MM3 Sales Forecast

MM3 Stock Forecast FAQ

Detailed List of Analyst Forecasts